Sven-Ove Ögren

What is he best known for?

The fields of study he is best known for:

• Dopamine
• Internal medicine
• Neurotransmitter

Sven-Ove Ögren mainly investigates Internal medicine, Endocrinology, Dopamine, Pharmacology and Dopamine receptor D2. His Internal medicine study frequently links to other fields, such as Neuroscience. His Endocrinology study incorporates themes from Neuropeptide and Monoamine neurotransmitter, Serotonin.

His work in the fields of Dopamine, such as Dopaminergic, Dopamine receptor, Dopamine receptor D1 and Raclopride, intersects with other areas such as Offspring. The concepts of his Dopaminergic study are interwoven with issues in Neurturin, GDNF family of ligands and Anatomy. The various areas that Sven-Ove Ögren examines in his Pharmacology study include Striatum, Receptor, Postsynaptic potential, Zimelidine and Antidepressant.

His most cited work include:

• Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo (1023 citations)
• Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain (470 citations)
• The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. (209 citations)

What are the main themes of his work throughout his whole career to date?

Sven-Ove Ögren mostly deals with Endocrinology, Internal medicine, Pharmacology, Neuroscience and Dopamine. The Endocrinology study combines topics in areas such as Agonist, Neuropeptide, Receptor, Galanin and Serotonin. His Receptor study combines topics in areas such as Cerebral cortex and Binding site.

Sven-Ove Ögren focuses mostly in the field of Internal medicine, narrowing it down to matters related to Desipramine and, in some cases, Neurotoxin. His research in Pharmacology focuses on subjects like Antidepressant, which are connected to Mechanism of action. His Dopamine receptor D2 research integrates issues from Dopaminergic and Catalepsy.

He most often published in these fields:

• Endocrinology (46.61%)
• Internal medicine (46.61%)
• Pharmacology (42.37%)

What were the highlights of his more recent work (between 2000-2020)?

• Internal medicine (46.61%)
• Endocrinology (46.61%)
• Pharmacology (42.37%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Endocrinology, Pharmacology, Neuroscience and Galanin. His study in the field of Muscarinic acetylcholine receptor, Microdialysis, 5-HT receptor and Agonist also crosses realms of Behavioural analysis. His research integrates issues of AMPA receptor and Neuroprotection in his study of Endocrinology.

The study incorporates disciplines such as Dopamine receptor D2, Dopamine, Male mice and Antagonism in addition to Pharmacology. His work investigates the relationship between Dopamine receptor D2 and topics such as Dopaminergic that intersect with problems in Tyrosine hydroxylase. He interconnects Hippocampus, Acetylcholine and Cholinergic in the investigation of issues within Galanin.

Between 2000 and 2020, his most popular works were:

• Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone (153 citations)
• Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. (84 citations)
• Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition. (80 citations)

In his most recent research, the most cited papers focused on:

• Dopamine
• Neurotransmitter
• Internal medicine

Sven-Ove Ögren focuses on Pharmacology, Endocrinology, Internal medicine, Dopamine and Neuroscience. His Pharmacology research is multidisciplinary, relying on both Male mice, Dopamine β hydroxylase, Anxiolytic and Zimelidine. His Endocrinology research is multidisciplinary, incorporating perspectives in Agonist and Galanin, Galanin receptor 2.

His research investigates the connection between Galanin and topics such as Microdialysis that intersect with issues in Acetylcholine and 5-HT receptor. His research in the fields of Dopaminergic and Dopamine receptor D2 overlaps with other disciplines such as Chlorphentermine. His studies deal with areas such as Antidepressant, 5-HT2A receptor, 5-HT6 receptor and Serotonergic as well as Dopamine receptor D2.